Press Release Details
Magenta Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference
The webcast of Magenta's presentation will be accessible at
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise to revolutionize immune and blood reset to allow more patients to take advantage of the curative potential of stem cell transplant as well as potentially improve eligibility for future gene therapies.
Magenta is based in
Source: Magenta Therapeutics